North America $372.9 Bn Injectable Drugs Markets, 2020-2021 & 2030 by Molecule Type, Drug Class, Delivery, Application, Distribution Channel – ResearchAndMarkets.com

North America $372.9 Bn Injectable Drugs Markets, 2020-2021 & 2030 by Molecule Type, Drug Class, Delivery, Application, Distribution Channel – ResearchAndMarkets.com




North America $372.9 Bn Injectable Drugs Markets, 2020-2021 & 2030 by Molecule Type, Drug Class, Delivery, Application, Distribution Channel – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “North America Injectable Drugs Market 2020-2030” report has been added to ResearchAndMarkets.com’s offering.

The North America injectable drugs market is expected to grow by 8.3% annually in the forecast period and reach $372.9 billion by 2030 driven by the increasing prevalence of chronic diseases, rising use of self-administered Injectable formulations, technological advancements in drug development, and growing approvals of new injectable drugs such as COVID-19 vaccines.

The trend and outlook of the North American market is forecast in optimistic, balanced, and conservative views by taking into account COVID-19. The balanced (most likely) projection is used to quantify North America’s injectable drugs market in every aspect of the classification from perspectives of Molecule Type, Drug Class, Delivery, Application, Distribution Channel, and Country.

Key Players (this may not be a complete list and extra companies can be added upon request):

  • Amgen Inc.
  • Baxter International Inc.
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Moderna, Inc.
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceuticals Industries Ltd.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter’s Five Forces Analysis

3 Segmentation of North America Market by Molecule Type

3.1 Market Overview by Molecule Type

3.2 Small Molecule

3.3 Large Molecule

4 Segmentation of North America Market by Drug Class

4.1 Market Overview by Drug Class

4.2 Monoclonal Antibodies (mAbs)

4.3 Immunoglobulin

4.4 Insulin

4.5 Vaccines

4.6 Cytokines

4.7 Peptide Hormone

4.8 Blood Factors

4.9 Other Drug Classes

5 Segmentation of North America Market by Delivery

5.1 Market Overview by Delivery

5.2 Pre-filled Syringe

5.3 Infusions

5.4 Other Deliveries

6 Segmentation of North America Market by Application

6.1 Market Overview by Application

6.2 Oncology

6.3 Infectious Diseases

6.4 Autoimmune Diseases

6.5 Cardiovascular Diseases

6.6 Pain

6.7 Neurology

6.8 Other Applications

7 Segmentation of North America Market by Distribution Channel

7.1 Market Overview by Distribution Channel

7.2 Hospital Pharmacy

7.3 Retail Pharmacy

7.4 E-Commerce

8 North America Market 2019-2030 by Country

8.1 Overview of North America Market

8.2 U.S.

8.3 Canada

8.4 Mexico

9 Competitive Landscape

9.1 Overview of Key Vendors

9.2 New Product Launch, Partnership, Investment, and M&A

9.3 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/cyhx2j

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900